BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rurik JG, Aghajanian H, Epstein JA. Immune Cells and Immunotherapy for Cardiac Injury and Repair. Circ Res 2021;128:1766-79. [PMID: 34043424 DOI: 10.1161/CIRCRESAHA.121.318005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Li X, Wang L, Ying X, Zheng Y, Tan Q, Yu X, Gong J, Li M, Deng X, Yang G, Li S, Jiang S. Electroacupuncture pre-treatment alleviates sepsis-induced cardiac inflammation and dysfunction by inhibiting the calpain-2/STAT3 pathway. Front Physiol 2022;13:961909. [DOI: 10.3389/fphys.2022.961909] [Reference Citation Analysis]
2 Tzahor E, Dimmeler S. A coalition to heal-the impact of the cardiac microenvironment. Science 2022;377:eabm4443. [PMID: 36048959 DOI: 10.1126/science.abm4443] [Reference Citation Analysis]
3 Li F, Liu D, Liu M, Ji Q, Zhang B, Mei Q, Cheng Y, Zhou S. Tregs biomimetic nanoparticle to reprogram inflammatory and redox microenvironment in infarct tissue to treat myocardial ischemia reperfusion injury in mice. J Nanobiotechnology 2022;20:251. [PMID: 35659239 DOI: 10.1186/s12951-022-01445-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Schmitt PR, Dwyer KD, Coulombe KLK. Current Applications of Polycaprolactone as a Scaffold Material for Heart Regeneration. ACS Appl Bio Mater 2022. [PMID: 35623101 DOI: 10.1021/acsabm.2c00174] [Reference Citation Analysis]
5 Filimon S, Pop C, Chetrit M, Esfahani K, Hudson M, Rouleau J, Thanassoulis G, O’meara E, Bouabdallaoui N, Michel C, Aziz H, Gold P, Tardif J, Huynh T. A New Era: Immunotherapy applied to Contemporary Cardiovascular Practice. Canadian Journal of Cardiology 2022. [DOI: 10.1016/j.cjca.2022.05.013] [Reference Citation Analysis]
6 Finck AV, Blanchard T, Roselle CP, Golinelli G, June CH. Engineered cellular immunotherapies in cancer and beyond. Nat Med 2022;28:678-89. [PMID: 35440724 DOI: 10.1038/s41591-022-01765-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Rurik JG, Epstein JA. Uniting Disciplines to Develop Therapeutics: Targeted mRNA Lipid Nanoparticles Reprogram the Immune System In Vivo to Treat Heart Disease. DNA Cell Biol 2022. [PMID: 35446147 DOI: 10.1089/dna.2022.0171] [Reference Citation Analysis]
8 Zhou J, He S, Wang B, Yang W, Zheng Y, Jiang S, Li D, Lin J. Construction and Bioinformatics Analysis of circRNA-miRNA-mRNA Network in Acute Myocardial Infarction. Front Genet 2022;13:854993. [PMID: 35422846 DOI: 10.3389/fgene.2022.854993] [Reference Citation Analysis]
9 Liu C, Fan Z, He D, Chen H, Zhang S, Guo S, Zheng B, Cen H, Zhao Y, Liu H, Wang L. Designer Functional Nanomedicine for Myocardial Repair by Regulating the Inflammatory Microenvironment. Pharmaceutics 2022;14:758. [DOI: 10.3390/pharmaceutics14040758] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Awwad L, Goldenberg T, Langier-goncalves I, Aronheim A. Cardiac Remodeling in the Absence of Cardiac Contractile Dysfunction Is Sufficient to Promote Cancer Progression. Cells 2022;11:1108. [DOI: 10.3390/cells11071108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Travers JG, Tharp CA, Rubino M, McKinsey TA. Therapeutic targets for cardiac fibrosis: from old school to next-gen. J Clin Invest 2022;132:e148554. [PMID: 35229727 DOI: 10.1172/JCI148554] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
12 Algoet M, Janssens S, Himmelreich U, Gsell W, Pusovnik M, Van den Eynde J, Oosterlinck W. 'Myocardial Ischemia-Reperfusion Injury and the Influence of Inflammation. Trends Cardiovasc Med 2022:S1050-1738(22)00029-9. [PMID: 35181472 DOI: 10.1016/j.tcm.2022.02.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
13 Kao TW, Huang CC. Inflammatory Burden and Immunomodulative Therapeutics of Cardiovascular Diseases. Int J Mol Sci 2022;23:804. [PMID: 35054989 DOI: 10.3390/ijms23020804] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Rurik JG, Tombácz I, Yadegari A, Méndez Fernández PO, Shewale SV, Li L, Kimura T, Soliman OY, Papp TE, Tam YK, Mui BL, Albelda SM, Puré E, June CH, Aghajanian H, Weissman D, Parhiz H, Epstein JA. CAR T cells produced in vivo to treat cardiac injury. Science 2022;375:91-6. [PMID: 34990237 DOI: 10.1126/science.abm0594] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 70.0] [Reference Citation Analysis]
15 Rurik JG, Tombácz I, Yadegari A, Méndez Fernández PO, Shewale SV, Li L, Kimura T, Soliman OY, Papp TE, Tam YK, Mui BL, Albelda SM, Puré E, June CH, Aghajanian H, Weissman D, Parhiz H, Epstein JA. CAR T cells produced in vivo to treat cardiac injury. Science 2022;375:91-6. [DOI: 10.1126/science.abm0594] [Reference Citation Analysis]
16 Liuzzo G, Volpe M. An inflammatory ageing clock to detect cardiovascular and other age-related diseases: a new approach to preventive medicine. Eur Heart J 2021;42:4296-7. [PMID: 34743213 DOI: 10.1093/eurheartj/ehab616] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Ravaud C, Ved N, Jackson DG, Vieira JM, Riley PR. Lymphatic Clearance of Immune Cells in Cardiovascular Disease. Cells 2021;10:2594. [PMID: 34685572 DOI: 10.3390/cells10102594] [Reference Citation Analysis]